| ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival W Weichert, T Knösel, J Bellach, M Dietel, G Kristiansen Journal of clinical pathology 57 (11), 1160-1164, 2004 | 359 | 2004 |
| Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis Y Chen, T Knösel, G Kristiansen, A Pietas, ME Garber, S Matsuhashi, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003 | 350 | 2003 |
| The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma TDA Australian Pancreatic Cancer Genome Initiative, Wessels LF, Wood SA ... Nature 486, 266-70, 2012 | 347 | 2012 |
| Effect of neoadjuvant chemotherapy plus regional hyperthermia on long-term outcomes among patients with localized high-risk soft tissue sarcoma: the EORTC 62961-ESHO 95 … RD Issels, LH Lindner, J Verweij, R Wessalowski, P Reichardt, P Wust, ... JAMA oncology 4 (4), 483-492, 2018 | 286 | 2018 |
| Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes C Winter, G Kristiansen, S Kersting, J Roy, D Aust, T Knösel, P Rümmele, ... PLoS computational biology 8 (5), e1002511, 2012 | 229 | 2012 |
| MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression AE Frampton, L Castellano, T Colombo, E Giovannetti, J Krell, J Jacob, ... Gastroenterology 146 (1), 268-277. e18, 2014 | 188 | 2014 |
| Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab T Köhnke, C Krupka, J Tischer, T Knösel, M Subklewe Journal of hematology & oncology 8, 1-5, 2015 | 179 | 2015 |
| International histopathology consensus for unilateral primary aldosteronism TA Williams, CE Gomez-Sanchez, WE Rainey, TJ Giordano, AK Lam, ... The Journal of Clinical Endocrinology & Metabolism 106 (1), 42-54, 2021 | 175 | 2021 |
| Nuclear export is essential for the tumor‐promoting activity of survivin SK Knauer, OH Krämer, T Knösel, K Engels, F Rödel, AF Kovács, ... The FASEB Journal 21 (1), 207-216, 2007 | 175 | 2007 |
| MRI of prostate cancer at 1.5 and 3.0 T: comparison of image quality in tumor detection and staging D Beyersdorff, K Taymoorian, T Knösel, D Schnorr, R Felix, B Hamm, ... American Journal of Roentgenology 185 (5), 1214-1220, 2005 | 170 | 2005 |
| Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer L Yang, Y Chen, T Cui, T Knösel, Q Zhang, KF Albring, O Huber, ... Carcinogenesis 33 (10), 1863-1870, 2012 | 159 | 2012 |
| Current diagnostics and treatment of fibrosarcoma–perspectives for future therapeutic targets and strategies D Augsburger, PJ Nelson, T Kalinski, A Udelnow, T Knösel, M Hofstetter, ... Oncotarget 8 (61), 104638, 2017 | 141 | 2017 |
| TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t (X; 18): analysis of 319 cases T Knösel, S Heretsch, A Altendorf-Hofmann, P Richter, K Katenkamp, ... European Journal of Cancer 46 (6), 1170-1176, 2010 | 129 | 2010 |
| Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma C Gordziel, J Bratsch, R Moriggl, T Knösel, K Friedrich British journal of cancer 109 (1), 138-146, 2013 | 125 | 2013 |
| Nuclear relocation of STAT6 reliably predicts NAB2–STAT6 fusion for the diagnosis of solitary fibrous tumour C Koelsche, L Schweizer, M Renner, A Warth, DTW Jones, F Sahm, ... Histopathology 65 (5), 613-622, 2014 | 123 | 2014 |
| Incidence of chromosomal imbalances in advanced colorectal carcinomas and their metastases T Knösel, S Petersen, H Schwabe, K Schlüns, U Stein, P Schlag, M Dietel, ... Virchows Archiv 440, 187-194, 2002 | 114 | 2002 |
| Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer T Knösel, A Emde, K Schlüns, Y Chen, K Jürchott, M Krause, M Dietel, ... Neoplasia 7 (8), 741-747, 2005 | 104 | 2005 |
| A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer R Rad, L Rad, W Wang, A Strong, H Ponstingl, IF Bronner, M Mayho, ... Nature genetics 47 (1), 47-56, 2015 | 103 | 2015 |
| Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells K Jürchott, RJ Kuban, T Krech, N Blüthgen, U Stein, W Walther, C Friese, ... PLoS genetics 6 (12), e1001231, 2010 | 102 | 2010 |
| Cytokeratin profiles identify diagnostic signatures in colorectal cancer using multiplex analysis of tissue microarrays T Knösel, V Emde, K Schlüns, PM Schlag, M Dietel, I Petersen Analytical Cellular Pathology 28 (4), 167-175, 2006 | 96 | 2006 |
Professor Adam E. FramptonHead of Oncology & Assoc. Professor in Surgical Oncology, Section of Oncology, FHMS, Uni. of Surrey在 surrey.ac.uk 的电子邮件经过验证
